Free Trial

Korro Bio (KRRO) Competitors

Korro Bio logo
$14.81 +0.01 (+0.07%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$15.15 +0.34 (+2.30%)
As of 05/22/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KRRO vs. BCYC, ANAB, COGT, VECT, SION, KROS, IMTX, TYRA, VALN, and MRVI

Should you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Bicycle Therapeutics (BCYC), AnaptysBio (ANAB), Cogent Biosciences (COGT), VectivBio (VECT), Sionna Therapeutics (SION), Keros Therapeutics (KROS), Immatics (IMTX), Tyra Biosciences (TYRA), Valneva (VALN), and Maravai LifeSciences (MRVI). These companies are all part of the "pharmaceutical products" industry.

Korro Bio vs.

Bicycle Therapeutics (NASDAQ:BCYC) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, community ranking, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Bicycle Therapeutics has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.66, indicating that its stock price is 166% more volatile than the S&P 500.

86.2% of Bicycle Therapeutics shares are held by institutional investors. Comparatively, 13.2% of Korro Bio shares are held by institutional investors. 22.9% of Bicycle Therapeutics shares are held by company insiders. Comparatively, 4.6% of Korro Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Bicycle Therapeutics received 114 more outperform votes than Korro Bio when rated by MarketBeat users. However, 100.00% of users gave Korro Bio an outperform vote while only 70.53% of users gave Bicycle Therapeutics an outperform vote.

CompanyUnderperformOutperform
Bicycle TherapeuticsOutperform Votes
146
70.53%
Underperform Votes
61
29.47%
Korro BioOutperform Votes
32
100.00%
Underperform Votes
No Votes

Korro Bio has lower revenue, but higher earnings than Bicycle Therapeutics. Bicycle Therapeutics is trading at a lower price-to-earnings ratio than Korro Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bicycle Therapeutics$25.72M21.81-$180.66M-$3.14-2.58
Korro Bio$4.82M28.85-$81.17M-$9.44-1.57

Bicycle Therapeutics currently has a consensus target price of $25.00, suggesting a potential upside of 208.64%. Korro Bio has a consensus target price of $102.43, suggesting a potential upside of 591.62%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts clearly believe Korro Bio is more favorable than Bicycle Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bicycle Therapeutics
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Korro Bio
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.29

Korro Bio has a net margin of 0.00% compared to Bicycle Therapeutics' net margin of -450.64%. Bicycle Therapeutics' return on equity of -27.35% beat Korro Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Bicycle Therapeutics-450.64% -27.35% -20.81%
Korro Bio N/A -50.25%-38.48%

In the previous week, Korro Bio had 1 more articles in the media than Bicycle Therapeutics. MarketBeat recorded 7 mentions for Korro Bio and 6 mentions for Bicycle Therapeutics. Bicycle Therapeutics' average media sentiment score of 1.18 beat Korro Bio's score of 0.59 indicating that Bicycle Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bicycle Therapeutics
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Korro Bio
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Korro Bio beats Bicycle Therapeutics on 10 of the 19 factors compared between the two stocks.

Get Korro Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRRO vs. The Competition

MetricKorro BioPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$139.08M$6.47B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-1.579.0626.7119.71
Price / Sales28.85251.50386.46120.65
Price / CashN/A65.8538.2534.62
Price / Book0.706.456.774.50
Net Income-$81.17M$143.98M$3.23B$248.22M
7 Day Performance-1.99%0.38%0.48%-0.78%
1 Month Performance-17.54%2.14%9.10%11.53%
1 Year Performance-69.20%-0.33%18.56%8.99%

Korro Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRRO
Korro Bio
2.0073 of 5 stars
$14.81
+0.1%
$102.43
+591.6%
-70.5%$139.08M$4.82M-1.5770Analyst Revision
Gap Down
BCYC
Bicycle Therapeutics
3.9262 of 5 stars
$8.60
+3.1%
$25.00
+190.7%
-62.2%$595.14M$25.72M-2.61240Gap Up
ANAB
AnaptysBio
3.3389 of 5 stars
$20.03
+2.2%
$35.88
+79.1%
-17.2%$588.48M$111.87M-3.29100Positive News
COGT
Cogent Biosciences
2.3545 of 5 stars
$5.13
+6.7%
$14.29
+178.5%
-38.4%$584.08MN/A-2.0780News Coverage
Positive News
Analyst Forecast
Analyst Revision
Gap Down
VECT
VectivBio
N/A$16.85
flat
N/AN/A$573.24M$27.34M0.0030High Trading Volume
SION
Sionna Therapeutics
N/A$12.90
+4.7%
$38.50
+198.4%
N/A$569.20MN/A0.0035News Coverage
Analyst Downgrade
Gap Down
KROS
Keros Therapeutics
3.2498 of 5 stars
$13.74
+0.7%
$37.00
+169.3%
-72.3%$558.05M$214.71M-2.64100
IMTX
Immatics
2.8104 of 5 stars
$4.56
+7.5%
$16.67
+265.5%
-49.7%$554.27M$155.84M-6.91260News Coverage
Positive News
Analyst Downgrade
Gap Up
TYRA
Tyra Biosciences
1.6664 of 5 stars
$10.26
+1.7%
$30.83
+200.5%
-45.8%$544.70MN/A-6.3720News Coverage
Positive News
Analyst Forecast
Analyst Revision
VALN
Valneva
2.1097 of 5 stars
$6.45
-0.3%
$15.50
+140.3%
-27.5%$539.45M$169.58M-49.62700
MRVI
Maravai LifeSciences
4.0599 of 5 stars
$2.12
+7.1%
$6.34
+199.2%
-79.2%$539.19M$259.19M-1.29610Gap Up

Related Companies and Tools


This page (NASDAQ:KRRO) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners